For the Quarter Ending September 2025
North America
• In USA, the Troxerutin Price Index fell modestly quarter-over-quarter, reflecting elevated global inventories and weaker import demand.
• Troxerutin Spot Price softened as suppliers offered discounts to clear surplus stocks amid subdued buying interest from domestic importers.
• Troxerutin Price Forecast suggests modest recovery in the coming months, supported by restocking and gradual improvement in import orders.
• Troxerutin Production Cost Trend remained stable, with global feedstock price fluctuations slightly easing landed costs for importers.
• Troxerutin Demand Outlook remains muted due to cautious pharmaceutical procurement and selective restocking from distributors.
• Troxerutin Price Index volatility reflected shifting export schedules, freight rate variations, and inventory adjustments at US ports.
• Aggressive supplier offers to reduce overseas inventory pressured landed prices and compressed margins for domestic importers.
Why did the price of Troxerutin change in September 2025 in North America?
• Elevated inventories at overseas suppliers and surplus production led to discounted offers, lowering landed import prices.
• Fluctuating feedstock costs abroad reduced manufacturing expenses, allowing sellers to offer Troxerutin at softer levels.
• Weak import demand from US distributors and cautious pharmaceutical procurement limited upward price momentum, despite smooth logistics.
APAC
• In China, the Troxerutin Price Index fell by 1.58% quarter-over-quarter, reflecting elevated inventories and weaker export demand.
• The average Troxerutin price for the quarter was approximately USD 38500/MT, measured on FOB Shanghai trade terms.
• Troxerutin Spot Price softened as sellers offered discounts to reduce surplus stocks amid subdued buying interest.
• Troxerutin Price Forecast suggests modest recovery driven by restocking and gradual export demand improvement later months.
• Troxerutin Production Cost Trend showed intermittent declines with fluctuating feedstock prices reducing manufacturing expenses marginally.
• Troxerutin Demand Outlook remains muted due to weak pharmaceuticals offtake and cautious importer restocking behaviour.
• Troxerutin Price Index volatility reflects shifting export orders, freight rate changes, and onshore inventory adjustments.
• Suppliers offered aggressive offers to clear excess inventory, pressuring sellers and compressing margins across domestic and export channels.
Why did the price of Troxerutin change in September 2025 in APAC?
• Elevated inventories and surplus production pressured prices, as sellers offered discounts to accelerate stock reductions.
• Declining feedstock costs lowered Troxerutin production expenses, reducing seller price thresholds and softening offers materially.
• Weak export demand and cautious importer restocking, despite smooth logistics, limited upward price momentum in September.
Europe
• In Netherlands, the Troxerutin Price Index declined modestly quarter-over-quarter, influenced by elevated inventories and softer import demand.
• Troxerutin Spot Price softened as suppliers offered discounts to clear surplus stocks, while European distributors purchased selectively.
• Troxerutin Price Forecast indicates modest recovery in the coming months, supported by restocking and gradual increase in import orders.
• Troxerutin Production Cost Trend remained relatively stable, with feedstock price fluctuations easing landed costs for importers.
• Troxerutin Demand Outlook remains muted due to cautious pharmaceutical procurement and limited cosmetic or nutraceutical restocking.
• Troxerutin Price Index volatility reflected shifting export schedules, freight variations, and European port inventory adjustments.
• Supplier discounting to reduce overseas stocks pressured landed prices, constraining immediate margin expansion for buyers.
Why did the price of Troxerutin change in September 2025 in Europe and the Netherlands?
• Elevated supplier inventories and surplus production led to softer import offers, pressuring landed costs.
• Fluctuating feedstock costs abroad reduced production expenses, allowing sellers to offer Troxerutin at lower levels.
• Cautious import procurement and muted downstream demand limited upward momentum despite efficient logistics.
For the Quarter Ending June 2025
North America
• Price Index for Troxerutin (Food grade) in the US showed a moderate downward adjustment in July 2025, in line with softening global prices and easing procurement activity.
• Spot Price of Troxerutin declined marginally from June levels, reflecting weaker overseas buying interest and price competition from lower-cost Asian exports.
• Price Forecast for August 2025 points to continued softness in prices amid elevated inventories and low-volume purchases from healthcare and nutraceutical sectors.
• Production Cost Trend remained neutral in July as feedstock costs stabilized, but import-driven supply from China saw lower landed costs due to falling FOB Shanghai rates.
• Demand Outlook stayed subdued as US buyers held back on fresh procurement, citing existing stockpiles and anticipation of further price declines in the near term.
• Why did the price change in July 2025?
Troxerutin prices in the US declined in July due to weakened import demand, ample inventories, and cheaper Chinese-origin material flowing in at discounted rates amid oversupply in APAC.
• Inventory, supply-demand dynamics, and regional cues pointed to cautious restocking behaviour, slow-moving inventories, and reduced urgency among distributors, as the market awaited potential Q3 buying clarity.
Europe
• Price Index for Troxerutin in Germany registered a notable downward correction in July 2025, influenced by weakened regional demand and influx of lower-cost imports from Asia.
• Spot Price exhibited a declining trend as importers adjusted offers downward to remain competitive against oversupplied Chinese-origin material.
• Price Forecast for August 2025 suggests continued bearish pressure due to high inventory levels, persistent downstream caution, and limited tender activity across pharmaceutical and dietary sectors.
• Production Cost Trend remained unchanged domestically, but cheaper Asian imports—driven by falling FOB Shanghai prices—led to overall lower procurement costs for European buyers.
• Demand Outlook remained lacklustre in July, with end-users deferring purchases amid ample warehouse stocks and weak consumption from health and wellness sectors.
• Why did the price change in July 2025?
Troxerutin prices in Germany declined due to reduced offtake, intense competition from low-cost Asian suppliers, and elevated inventory levels held by importers and formulators.
• Inventory, supply-demand dynamics, and regional cues indicate cautious procurement patterns, minimal contractual buying, and hesitancy among formulators to engage in bulk purchases, awaiting further price correction in Q3.
APAC
• Price Index for Troxerutin (Food grade) in APAC trended downward in July 2025, following a sharp decline from USD 38,000/MT in June 2025 FOB Shanghai, reflecting weakened fundamentals.
• Spot Price for Troxerutin in China dropped significantly in July, driven by continued inventory overhang from earlier stockpiling and weak global offtake, particularly from the pharmaceutical and nutraceutical sectors.
• Price Forecast for August 2025 remains bearish due to sustained exporter discounting and soft overseas inquiries, although domestic replenishment demand may limit the extent of further decline.
• Production Cost Trend in China stayed subdued in July, with raw material prices stabilizing at lower levels and factory activity remaining muted, providing minimal cost-side support to Troxerutin values.
• Demand Outlook remained underwhelming, as overseas procurement interest was sluggish for the fourth consecutive month, with major buyers in the US and Europe holding back amid high inventories and freight uncertainties.
• In July 2025, Troxerutin prices in China declined primarily due to excess stock levels and export resistance. The Chinese Yuan’s appreciation against the US Dollar further dented competitiveness of Chinese cargoes abroad.
• Sellers faced margin pressure due to sustained weak demand and were compelled to extend lower offers to secure limited bookings, resulting in downward pressure on FOB values.
• Freight rates remained elevated, eroding cost advantages for long-haul exports and discouraging forward contracts from Europe and North America.
• Domestic demand showed only a modest uptick, insufficient to counterbalance weak international flow; buyers remained cautious in anticipation of further downside risks.
• Export momentum weakened sharply as global demand for dietary supplement ingredients stagnated, with key US and EU buyers focusing on clearing existing inventories instead of restocking.
